![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1766360
Áú ½½¸µ ½ÃÀå : ½ÃÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м® ¹× ¿¹Ãø(2025-2034³â)Vaginal Slings Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
¼¼°èÀÇ Áú ½½¸µ ½ÃÀåÀº 2024³â 18¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í 2034³â¿¡´Â 41¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, CAGR 8.2%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÁÖ¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀº ÁÖ·Î ¿ä½Ç±Ý »ç·ÊÀÇ Áõ°¡, ¿©¼ºµéÀÇ °ñ¹ÝÀú ±â´É¿¡ ´ëÇÑ ÀÎ½Ä Á¦°í, ½½¸µ Àç·á ¹× ¼ö¼ú ¹æ¹ýÀÇ ¹ßÀü¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. °ø°ø ÀÎ½Ä Ä·ÆäÀÎ, ¿ËÈ£ Ȱµ¿, ±³À° ÇÁ·Î±×·¥ µîÀ» ÅëÇØ ¿©¼ºµéÀÌ ÀÌ¿ë °¡´ÉÇÑ Ä¡·á¹ý¿¡ ´ëÇØ ´õ ¸¹ÀÌ ¾Ë°Ô µÇ¸é¼, Á¶±â Áø´Ü°ú ¼ö¼ú ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ëµµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Èí¼ö¼º ¹× °æ·® ¼ÒÀç¿Í °°Àº ½½¸µ µðÀÚÀÎÀÇ ±â¼úÀû Áøº¸´Â ¼ö¼ú °á°ú¿Í ȯÀÚ ¸¸Á·µµ¸¦ °³¼±Çß½À´Ï´Ù. ¿Ü·¡ ¼ö¼ú·Î ÀüȯµÇ´Â Ãß¼¼´Â ºñ¿ë È¿À²¼º, ªÀº ȸº¹ ½Ã°£, °íǰÁú Ä¡·á¸¦ Á¦°øÇÔÀ¸·Î½á ÀÇ·á ±â°ü Àü¹Ý¿¡¼ ÀüüÀûÀΠäÅ÷üÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ÃÖ¼Ò Ä§½ÀÀûÀ̰í ȯÀÚ Ä£ÈÀûÀÎ ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä´Â Á¦Ç° °³¹ßÀ» °è¼ÓÇØ¼ ÁÖµµÇϰí ÀÖÀ¸¸ç, ¾÷°è Àü¹Ý¿¡ °ÉÃÄ ¼ÒºñÀÚÀÇ ¼±Åÿ¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.
2024³â¿¡´Â °æ°ñ°ñ¹Ý ½½¸µ ºÎ¹®ÀÌ ½ÃÀåÀ» ÁÖµµÇϸç 7¾ï 3,920¸¸ ´Þ·¯ÀÇ °¡Ä¡¸¦ ´Þ¼ºÇß½À´Ï´Ù. ÀÌ ¹æ¹ýÀº Áß¿äÇÑ Ç÷°ü ¹× ½Å°æ ºÎÀ§¸¦ ÇÇÇÏ¿© ÇÕº´ÁõÀ» ÁÙÀÓÀ¸·Î½á ´õ ¾ÈÀüÇÑ ´ë¾ÈÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ½½¸µÀº Ä¡°ñ ÈĺΠºÎÀ§¸¦ ¿ìȸÇÏ¿© È¿°úÀûÀÎ ÁöÁö·ÂÀ» Á¦°øÇÏ¸é¼ ¿Ü»óÀ» ÃÖ¼ÒÈÇÕ´Ï´Ù. ÀÌ Á¦Ç°ÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÏ´Â °ÍÀº ¾ÈÀü¼º Çâ»ó, »ðÀÔ ¿ëÀ̼º ¹× À¯¸®ÇÑ È¯ÀÚ °á°ú¿Í °ü·ÃÀÌ ÀÖ½À´Ï´Ù. ¸¹Àº Á¦Á¶¾÷üµéÀÌ ÀÌ·¯ÇÑ ¿ä±¸ »çÇ×À» ÃæÁ·Çϱâ À§ÇØ Á¦Ç° ¼³°è¸¦ °³¼±ÇÏ¿© ºÎ¹®ÀÇ ¼ºÀå°ú »ç¿ëÀÚ ½Å·Ú¸¦ ³ôÀÌ´Â µ¥ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§ | |
---|---|
½ÃÀÛ ¿¬µµ | 2024³â |
¿¹Ãø ¿¬µµ | 2025-2034³â |
½ÃÀÛ ±Ý¾× | 18¾ï ´Þ·¯ |
¿¹Ãø ±Ý¾× | 41¾ï ´Þ·¯ |
CAGR | 8.2% |
2024³â ±âÁØ ½ºÆ®·¹½º ¿ä½Ç±ÝÀÌ Áú ½½¸µ ½ÃÀå Á¡À¯À²ÀÇ 41.2%¸¦ Â÷ÁöÇß½À´Ï´Ù. ³ë·É Àα¸, ƯÈ÷ ¿©¼ºÀÇ Áõ°¡·Î °ñ¹ÝÀú ±ÙÀ° ¾àÈ À§ÇèÀÌ ³ô¾ÆÁö¸ç, ÀÌ´Â ½ºÆ®·¹½º ¿ä½Ç±ÝÀ¸·Î À̾îÁý´Ï´Ù. ¹Ì±¹ alone¿¡¼ ¼ö¹é¸¸ ¸íÀÇ ¼ºÀÎ ¿©¼º¿¡°Ô ¿µÇâÀ» ¹ÌÄ¡´Â ÀÌ ÁúȯÀº ½É°¢ÇÑ ÀÇ·á ºÎ´ãÀ» ÃÊ·¡ÇÕ´Ï´Ù. Áú ½½¸µÀº ³ë·É Àα¸¿¡¼ ÀÌ·¯ÇÑ Áõ»óÀ» °ü¸®ÇÏ´Â ½Å·ÚÇÒ ¼ö ÀÖ°í È¿°úÀûÀÎ Ä¡·á ¿É¼ÇÀ¸·Î ÀÚ¸®¸Å±èÇß½À´Ï´Ù. ¿©¼ºÀÇ ºñ´¢±â °Ç°¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼, ƯÈ÷ ÅëÁõ¼º ¹æ±¤ ÁõÈıº°ú °°Àº Áúȯ¿¡ ´ëÇÑ °ü½ÉÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿ä½Ç±Ý °ü·Ã ¹®Á¦ ÇØ°áÀ» ¸ñÇ¥·Î ÇÑ °úÇÐÀû ¿¬±¸¿Í Á¦Ç° Çõ½ÅÀÌ °¡¼Óȵǰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ¸ÂÃãÇü, ¾ÈÀüÇϰí È¿À²ÀûÀÎ Ä¡·á ¿É¼ÇÀÎ ÀڱðæºÎ ½½¸µ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
¹Ì±¹ÀÇ Áú ½½¸µ ½ÃÀåÀº 2024³â¿¡ 3¾ï 9,680¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. ÀÌ ½ÃÀåÀº ½ºÆ®·¹½º¼º ¿ä½Ç±Ý(SUI)À¸·Î °íÅë¹Þ´Â ¿©¼º, ƯÈ÷ °í·É Àα¸ÀÇ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó ²ÙÁØÇÑ ¼ºÀåÀ» º¸À̰í ÀÖ½À´Ï´Ù. °ñ¹Ý °Ç°¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í Àü¹® ºñ´¢±â°ú ¼¾ÅÍ¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Çâ»óµÊ¿¡ µû¶ó ´õ ¸¹Àº ¿©¼ºµéÀÌ ¿ä½Ç±Ý Ä¡·á¸¦ ¹Þ±â ½ÃÀÛÇß½À´Ï´Ù. ºñ¸¸, Ãâ»ê, Æó°æ°ú °°Àº ¿äÀεéÀÌ °ñ¹ÝÀú ±â´É Àå¾ÖÀÇ ¹ßº´·üÀ» °è¼Ó ³ôÀÓ¿¡ µû¶ó Áú ½½¸µ°ú °°Àº ¿Ü°úÀû °³ÀÔ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½½¸µ Àç·áÀÇ ¹ßÀü°ú ÃÖ¼Ò Ä§½À ¼ö¼ú ±â¹ýÀÇ Ã¤ÅÃÀ¸·Î ½Ã¼ú È¿À²ÀÌ Çâ»óµÇ°í ȸº¹ ½Ã°£ÀÌ ´ÜÃàµÇ¸ç Àü¹ÝÀûÀΠȯÀÚ ¸¸Á·µµ°¡ ³ô¾ÆÁö°í ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ ¸ðµç ¿äÀεéÀÌ ½ÃÀå È®ÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °·ÂÇÑ ÀÇ·á ÀÎÇÁ¶ó¿Í À¯¸®ÇÑ º¸Çè ȯ±Þ Á¤Ã¥ÀÌ ¹Ì±¹ Àü¿ªÀÇ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
Àü ¼¼°è Áú ½½¸µ ½ÃÀå¿¡¼ Ȱµ¿ÇÏ´Â ÁÖ¿ä ±â¾÷À¸·Î´Â UroCure, A.M.I., Betatech, Coloplast, UNISUR, Boston Scientific, ADLER, Promedon, CALDERA MEDICAL, Johnson & Johnson, COUSIN SURGERY, neomedic international, LOTUS ¹× B. BraunÀÌ ÀÖ½À´Ï´Ù. Áú ½½¸µ ½ÃÀå¿¡¼ ÀÔÁö¸¦ °ÈÇϱâ À§ÇØ ÁÖ¿ä ¾÷üµéÀº Çõ½Å, Á¢±Ù¼º, Àü ¼¼°è ÁøÃâÀ» ¸ðµÎ ÁßÁ¡ÀûÀ¸·Î ÃßÁøÇϰí ÀÖ½À´Ï´Ù. ¸¹Àº ±â¾÷µéÀÌ ºü¸¥ ȸº¹À» Áö¿øÇÏ°í ¼ö¼úÀÇ º¹À⼺À» ÁÙÀÌ´Â °æ·®, »ýü ÀûÇÕ¼º, ȯÀÚ Áß½ÉÀÇ ½½¸µ ¼ÒÀç·Î Á¦Ç° ¶óÀÎÀ» °ÈÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ±â°ü ¹× ¿Ü°úÀǵé°ú Àü·«Àû Çù·ÂÀ» ÅëÇØ ½Ã¼ú äÅà ¹× Á¦Ç° Çǵå¹éÀ» °³¼±Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±â¾÷µéÀº Áö¸®Àû ¹üÀ§¸¦ È®´ëÇϱâ À§ÇØ ÀÓ»ó ½ÃÇè ¹× ±ÔÁ¦ ½ÂÀÎÀ» À§ÇÑ ÅõÀÚµµ ÁøÇàÇϰí ÀÖ½À´Ï´Ù.
The Global Vaginal Slings Market was valued at USD 1.8 billion in 2024 and is estimated to grow at a CAGR of 8.2% to reach USD 4.1 billion by 2034. This notable expansion is primarily driven by a rise in urinary incontinence cases, increased awareness of pelvic floor conditions among women, and advancements in sling materials and surgical methods. An increasing number of women are becoming more informed about available treatments due to public awareness campaigns, advocacy initiatives, and educational programs. These efforts have encouraged earlier diagnosis and increased acceptance of surgical options. Additionally, technological progress in sling design, such as absorbable and lightweight materials, has improved procedural outcomes and patient satisfaction. The shift toward outpatient procedures, which offer cost-effectiveness, shorter recovery times, and high-quality care, is also boosting overall adoption across healthcare settings. Demand for minimally invasive and patient-friendly procedures continues to shape product development and influence consumer choices across the industry.
The transobturator slings segment led the market in 2024, reaching a valuation of USD 739.2 million. This method offers a safer alternative by avoiding critical vascular and nerve zones, thereby reducing complications. By bypassing the retropubic area, these slings minimize trauma while delivering effective support. Their increasing adoption is linked to improved safety, ease of placement, and favorable patient outcomes. Many manufacturers have refined their product designs to accommodate these requirements, contributing to higher segment growth and user trust.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $1.8 Billion |
Forecast Value | $4.1 Billion |
CAGR | 8.2% |
In 2024, stress incontinence held the largest share at 41.2% of the vaginal slings market. The growing elderly population, particularly women, faces higher risks of pelvic floor weakening, which often results in stress urinary incontinence. With millions of adult females affected in the U.S. alone, this condition presents a significant healthcare burden. Vaginal slings offer a reliable and effective treatment for managing these symptoms in aging demographics. Rising awareness surrounding women's urological health, particularly conditions like painful bladder syndrome, has further accelerated scientific research and product innovations targeting incontinence-related issues. As a result, the demand for tailored, safe, and efficient treatment options like vaginal slings continues to rise.
U.S. Vaginal Slings Market was valued at USD 396.8 million in 2024. The market is experiencing steady growth driven by the rising number of women-particularly in the aging population-affected by stress urinary incontinence (SUI). Heightened awareness around pelvic health, along with increased access to specialized urogynecology centers, has encouraged more women to pursue treatment for urinary incontinence. Contributing factors such as obesity, childbirth, and menopause continue to raise the incidence of pelvic floor disorders, leading to higher demand for surgical interventions like vaginal slings. Advancements in sling materials and the adoption of minimally invasive surgical techniques are improving procedural efficiency, shortening recovery times, and enhancing overall patient satisfaction, all of which support market expansion.Additionally, strong healthcare infrastructure combined with favorable reimbursement policies is further propelling market growth across the U.S.
Leading companies active in the Global Vaginal Slings Market include: UroCure, A.M.I., Betatech, Coloplast, UNISUR, Boston Scientific, ADLER, Promedon, CALDERA MEDICAL, Johnson & Johnson, COUSIN SURGERY, neomedic international, LOTUS, and B. Braun. To strengthen their position in the vaginal slings market, key players are focusing on a mix of innovation, accessibility, and global outreach. Many companies are enhancing product lines with lightweight, biocompatible, and patient-centric sling materials that support quicker recovery and reduce surgical complexity. Strategic collaborations with healthcare institutions and surgeons help improve procedural adoption and product feedback. Firms are also investing in clinical trials and regulatory approvals to expand their geographic reach.